Dnalite Therapeutics, Inc.
ID: 7015325DNALite Therapeutics, Inc. is a biotechnology company focused on developing prevention and treatment for gastrointestinal diseases.
4
Funding Rounds
$10.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti***** Da* |
|
- | linkedin twitter |
| Mu**** Ah*** |
|
- |
Funding series
Funding Series Analysis
The company Dnalite Therapeutics, Inc. has raised a total of $8.93m in funding over 4 rounds.
Key Insights:
- Dnalite Therapeutics, Inc. Funding Round, April 2022: $8.93m
- DNAlite Therapeutics Inc funding round, August 2018: $1.5m
Industries
Dnalite Therapeutics, Inc. is active in the following industries: